Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) Revenue (2016 - 2026)

Rockwell Medical filings provide 16 years of Revenue readings, the most recent being $18.3 million for Q4 2025.

  • On a quarterly basis, Revenue fell 25.62% to $18.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $69.3 million, a 31.76% decrease, with the full-year FY2025 number at $69.3 million, down 31.76% from a year prior.
  • Revenue hit $18.3 million in Q4 2025 for Rockwell Medical, up from $15.9 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $28.3 million in Q3 2024 to a low of $15.1 million in Q2 2021.
  • Median Revenue over the past 5 years was $18.7 million (2022), compared with a mean of $19.5 million.
  • Biggest five-year swings in Revenue: surged 42.88% in 2024 and later plummeted 43.75% in 2025.
  • Rockwell Medical's Revenue stood at $15.3 million in 2021, then grew by 25.97% to $19.3 million in 2022, then increased by 14.39% to $22.1 million in 2023, then increased by 11.64% to $24.7 million in 2024, then fell by 25.62% to $18.3 million in 2025.
  • The last three reported values for Revenue were $18.3 million (Q4 2025), $15.9 million (Q3 2025), and $16.1 million (Q2 2025) per Business Quant data.